Date: April 9-10, 2015 Venue: Hotel Westin, Mumbai
Date: April 9-10, 2015
Venue: Hotel Westin, Mumbai
Organiser: Alliance India
Summary: Asia has a population of around 4.3 billion and is home to about 60 per cent of the world’s population. China alone has a population of approximately 1.3 billion, which is three- to fourfold bigger than Europe or the US. Adding in the other developing markets, such as those in Latin America, this makes for a huge potential market for the pharmaceutical industry, and one important not to miss.
The growth markets popularly include Brazil, Russia, India, China – the BRICs however Mexico, South Korea, and Turkey are now added to BRICs to be known as the BRIC-MST countries. In terms of the submission format, countries are beginning to move closer to the international submission template (eCTD — electronic common technical document). Similarly, the trend is toward more harmonisation in legal frameworks among the countries. For example, China’s regulatory processes are evolving, creating a framework that is more closely aligned to the US and European legislation and in both South Korea and China, the regulatory agency has been raised to the ministry level.
Mob: +91 9619633320